Skip to Main Content

Paper Details

Morphological cell profiling of SARS-CoV-2 infection identifies drug repurposing candidates for COVID-19.
Proc Natl Acad Sci U S A
134
2021
COVID-19, CoV-2, ERK, MEK, Raf, Ras, SARS, SARS-, SARS-CoV, SARS-CoV-2, alveolar epithelial type 2 cells, cell lines, coronavirus 2, iAEC2s, interferon, lactoferrin, lymph node carcinoma of the prostate, lymph node carcinoma of the prostate (LNCaP) cells, severe acute respiratory syndrome coronavirus
Author NameAffiliation
Tristan FrumUniversity of Michigan ann arbor
Tristan FrumUniversity of Michigan ann arbor
Matthew J O'MearaUniversity of Michigan ann arbor
Arul M ChinnaiyanMichigan Center for Translational Pathology, University of Michigan ann arbor
Arul M ChinnaiyanUniversity of Michigan ann arbor
Arul M ChinnaiyanRogel Cancer Center, University of Michigan ann arbor
Arul M ChinnaiyanUniversity of Michigan ann arbor
Arul M ChinnaiyanUniversity of Michigan ann arbor
Arul M ChinnaiyanMichigan Center for Translational Pathology, University of Michigan ann arbor
Arul M ChinnaiyanUniversity of Michigan ann arbor
Arul M ChinnaiyanRogel Cancer Center, University of Michigan ann arbor
Arul M ChinnaiyanUniversity of Michigan ann arbor
Arul M ChinnaiyanUniversity of Michigan ann arbor
  • 1 - 13

Datasets

Release 1.2